Genetic analysis of MEFV gene pyrin domain in patients with Behçet's disease

Mediators of Inflammation

Volumn 2006, Issue , 2006, Pages

  Dursun, Ahmet ^a   Durakbasi Dursun, Hatice Gul ^b   Zamani, Ayse Gul ^b   Gulbahar, Zerrin Gülin ^c   Dursun, Recep ^d   Yakicier, Cengiz ^c  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

^b SELCUK UNIVERSITY   (Turkey)

^c BILKENT UNIVERSITY   (Turkey)

^d BASKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

MEFV PROTEIN; PROTEIN; UNCLASSIFIED DRUG; CYTOSKELETON PROTEIN; MARENOSTRIN;

ARTICLE; BEHCET DISEASE; BONE MARROW CELL; FEMALE; GENE DELETION; GENE EXPRESSION; GENE INSERTION; GENE INTERACTION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; TURKEY (REPUBLIC); VASCULITIS; CHEMISTRY; DNA SEQUENCE; GENETICS; MUTATION; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

BEHCET SYNDROME; CYTOSKELETAL PROTEINS; HUMANS; MUTATION; POLYMERASE CHAIN REACTION; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ANALYSIS, DNA;

EID: 33645536424     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/MI/2006/41783     Document Type: Article

References (32)

1. T Sakane, M Takeno, N Suzuki, and G Inaba. Behçet's disease. The New England Journal of Medicine. 1999;341(17):1284-1291.
2. A Gul. Behçet's disease: an update on the pathogenesis. Clinical and Experimental Rheumatology. 2001;19(5 suppl 24):S6-S12.
3. M Zierhut, N Mizuki, S Ohno, et al. Immunology and functional genomics of Behçet's disease. Cellular and Molecular Life Sciences. 2003;60(9):1903-1922.
4. I Aksentijevich, M Centola, Z-M Deng, et al. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell. 1997;90(4):797-807.
5. P Atagunduz, T Ergun, and H Direskeneli. MEFV mutations are increased in Behçet's disease (BD) and are associated with vascular involvement. Clinical and Experimental Rheumatology. 2003;21(4 suppl 30):S35-S37.
6. N Imirzalioglu, A Dursun, B Tastan, Y Soysal, and M C Yakicier. MEFV gene is a probable susceptibility gene for Behçet's disease. Scandinavian Journal of Rheumatology. 2005;34(1):56-58.
7. The French FMF Consortium. A candidate gene for familial Mediterranean fever. Nature Genetics. 1997;17(1):25-31.
8. M Centola, G Wood, D M Frucht, et al. The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood. 2000;95(10):3223-3231.
9. E Mansfield, J J Chae, H D Komarow, et al. The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filaments. Blood. 2001;98(3):851-859.
10. D L Kastner and J J O'Shea. A fever gene comes in from the cold. Nature Genetics. 2001;29(3):241-242.
11. J Bertin and P S DiStefano. The PYRIN domain: a novel motif found in apoptosis and inflammation proteins. Cell Death and Differentiation. 2000;7(12):1273-1274.
12. T Chajek and M Fainaru. Behçet's disease report of 41 cases and a review of the literature. Medicine. 1975;54(3):179-195.
13. The International Study Group for Behçet's disease. Evaluation of diagnostic ('classification') criteria in Behçet's disease-towards internationally agreed criteria. British Journal of Rheumatology. 1992;31(5):299-308.
14. T Pawson and P Nash. Protein-protein interactions define specificity in signal transduction. Genes & Development. 2000;14(9):1027-1047.
15. K Hofmann. The modular nature of apoptotic signaling proteins. Cellular and Molecular Life Sciences. 1999;55(8-9):1113-1128.
16. C H Weber and C Vincenz. The death domain superfamily: a tale of two interfaces? Trends in Biochemical Sciences. 2001;26(8):475-481.
17. E Liepinsh, R Barbals, E Dahl, A Sharipo, E Staub, and G Otting. The death-domain fold of the ASC PYRIN domain, presenting a basis for PYRIN/PYRIN recognition. Journal of Molecular Biology. 2003;332(5):1155-1163.
18. A G Murzin, S E Brenner, T Hubbard, and C Chothia. SCOP: a structural classification of proteins database for the investigation of sequences and structures. Journal of Molecular Biology. 1995;247(4):536-540.
19. F Martinon, K Hofmann, and J TschoThe PYRIN domain: a possible member of the death domain-fold family implicated in apoptosis and inflammation. Current Biology. 2001;11(4):R118-R120.
20. J Masumoto, T A Dowds, P Schaner, et al. ASC is an activating adaptor for NF-kappa B and caspase-8-dependent apoptosis. Biochemical and Biophysical Research Communications. 2003;303(1):69-73.
21. J J Chae, H D Komarow, J Cheng, et al. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Molecular Cell. 2003;11(3):591-604.
22. C A Wise, J D Gillum, C E Seidman, et al. Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Human Molecular Genetics. 2002;11(8):961-969.
23. N G Shoham, M Centola, E Mansfield, et al. Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proceedings of the National Academy of Sciences of the United States of America. 2003;100(23):13501-13506.
24. N Richards, P Schaner, A Diaz, et al. Interaction between PYRIN and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis. The Journal of Biological Chemistry. 2001;276(42):39320-39329.
25. M Shiohara, S Taniguchi, J Masumoto, et al. ASC, which is composed of a PYD and a CARD, is up-regulated by inflammation and apoptosis in human neutrophils. Biochemical and Biophysical Research Communications. 2002;293(5):1314-1318.
26. J Masumoto, S Taniguchi, J Nakayama, et al. Expression of apoptosis-associated speck-like protein containing a caspase recruitment domain, a PYRIN N-terminal homology domain-containing protein, in normal human tissues. The Journal of Histochemistry and Cytochemistry. 2001;49(10):1269-1275.
27. C Stehlik, M Krajewska, K Welsh, S Krajewski, A Godzik, and J C Reed. The PAAD/PYRIN-only protein POP1/ASC2 is a modulator of ASC-mediated nuclear-factor-κ B and pro-caspase-1 regulation. The Biochemical Journal. 2003;373(pt 1):101-113.
28. F Martinon, K Burns, and J TschoThe inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Molecular Cell. 2002;10(2):417-426.
29. F Martinon and J TschoInflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell. 2004;117(5):561-574.
30. H M Hoffman, J L Mueller, D H Broide, A A Wanderer, and R D Kolodner. Mutation of a new gene encoding a putative PYRIN-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nature Genetics. 2001;29(3):301-305.
31. L Fiorentino, C Stehlik, V Oliveira, M E Ariza, A Godzik, and J C Reed. A novel PAAD-containing protein that modulates NF-κ B induction by cytokines tumor necrosis factor-α and interleukin-1β. The Journal of Biological Chemistry. 2002;277(38):35333-35340.
32. J A Harton, M W Linhoff, J Zhang, and J P Ting. Cutting edge: CATERPILLER: a large family of mammalian genes containing CARD, PYRIN, nucleotide-binding, and leucine-rich repeat domains. Journal of Immunology. 2002;169(8):4088-4093.